Test Code EBVP EBV Antibody Panel
EHR Test Codes
| Test Code | Test Name | |
| Atlas | EBVP | Epstein-Barr Virus Antibody Panel |
| Cerner | EBV Antibody Panel |
Specimen Requirements
Preparation of Patient:
None
Container Type:
Gold Top 6mL SST Gel & Clot Activator Tube
Specimen Type:
Serum
Specimen Volume:
2.5 mL Serum minimum 0.3 mL
Specimen Handling/Transport:
Transport refrigerated 2 - 8°C
Specimen Stability/Storage:
2 days refrigerated 2 - 8°C
7 days frozen -20°C
Specimen Rejection:
Gross hemolysis
Gross lipemia
Gross icterus
Performing Laboratory
Munson Medical Center Laboratories
Chemistry Department
Priority, Frequency, & Turnaround
Priority:
Non-Emergent
Frequency:
Wednesday
Turnaround:
0 - 7 days
Methodology
Chemiluminescence Immunoassay
Panel Includes: EBV Viral Capsid Antigen IgM (VCA IgM), EBV Viral Capsid Antigen IgG (VCA IgG), EBV Early Antigen IgG (EA), and Epstein-Barr Nuclear Antigen IgG (EBNA)
Reporting
Reference Range:
Negative
Interpretive Data:
Equivocal result indicates that a second sample should be retested in no less than 1 to 2 weeks, if clinically indicated.
Flow Diagram:
The accurate distinction of a primary (acute) infection from seronegative status or past infection is a key concern of EBV diagnostics. The presence of other EBV serological markers should be determined to assess the immunological status to infection with EBV. Based on the results of antibody tests, distinct serological profiles have been described in the medical literature.
| Condition | VCA IgM | VCA IgG | EBNA | EBV EA |
| No Past Infection | - | - | - | - |
| Past Infection | - | + | + | - |
| Acute Infection | + | + | - | + |
| Recent Infection | ± | + | + | ± |
| Convalescent | + | + | + | + |
Because some individuals are reported to exhibit long-lasting EBV VCA IgM antibodies, the convalescent pattern may represent a transient period late in the primary infection stage or may persist well into the past infection stage. Thus, it is considered an indeterminate pattern. For samples that exhibit indeterminate patterns, further diagnostic testing may be required. In all cases, diagnosis of infectious diseases should not be established on the basis of a single test result, but should be determined in conjunction with clinical findings and other diagnostic procedures as well as in association with medical judgment
Critical Decision:
None
Clinical Significance
Epstein-Barr virus (EBV) is responsible for infectious mononucleosis (IM) and is implicated in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibody response profiles for the different EBV antigens demonstrate a characteristic pattern for silent primary or persistent latent EBV infections, as well as for each of the EBV-associated diseases.
CPT Code(s)
86663
86664
86665
86666